Research · PMID 21810811 · Landmark study
Review date on record: Sep 2026. Named clinician approval is not independently verified on this page.
Endovascular stent graft repair of left renal artery pseudoaneurysm from malignant fibrous histiosarcoma.
Perspectives in vascular surgery and endovascular therapy · December 2011 · Warren M Perry, Carter Freiburg, Bart E Muhs, Jeffrey Indes
What this study found
A renal artery pseudoaneurysm is a rare but life-threatening complication. Historically, these vascular abnormalities have been treated using open surgery, but today's endovascular techniques provide less invasive forms of treatment.
Why this trial matters
Sniderman ApoB vs LDL-C
How RAGMD uses this study
Clinical questions this paper informs
Synthesis lives on the evidence question — this page shows where the study sits in that analysis.
Supporting literature
Is ApoB more useful than LDL-C for cardiovascular risk prediction?
Prospective cohorts and meta-analyses suggest ApoB may capture atherogenic particle burden better than LDL-C alone, particularly when triglycerides are elevated or LDL particles are discordant with LDL-C.
Open evidence analysis